Lynchwood Diagnostics Limited Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 07318073

Lynchwood Diagnostics Limited

Filleted Unaudited Abridged Financial Statements

31 December 2025

Lynchwood Diagnostics Limited

Abridged Financial Statements

Year Ended 31 December 2025

Contents	Pages

Officers and professional advisers	1

Abridged statement of financial position	2 to 3

Notes to the abridged financial statements	4 to 6

Lynchwood Diagnostics Limited

Officers and Professional Advisers

Director	Mr P Bates

Registered office	88 High Street
	Ramsey
	Huntingdon
	Cambs
	PE26 1BS

Accountants	SR Howell & Co
	Chartered Certified Accountants
	88 High Street
	Ramsey
	Huntingdon
	Cambs
	PE26 1BS

Lynchwood Diagnostics Limited

Abridged Statement of Financial Position

31 December 2025

	2025	2024
Note	£	£

Fixed assets

Tangible assets	5	902	1,203

Current assets

Stocks	7,703	10,609
Debtors	4,456	6,313
Cash at bank and in hand	58	1,199
	--------	--------
	12,217	18,121

Creditors: amounts falling due within one year	( 27,159)	( 23,986)
	--------	--------
Net current liabilities	( 14,942)	( 5,865)
	--------	-------
Total assets less current liabilities	( 14,040)	( 4,662)

Creditors: amounts falling due after more than one year	–	( 1,950)
	--------	-------
Net liabilities	( 14,040)	( 6,612)
	--------	-------

Capital and reserves

Called up share capital	1,300	1,300
Profit and loss account	( 15,340)	( 7,912)
	--------	-------
Shareholders deficit	( 14,040)	( 6,612)
	--------	-------

These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the abridged statement of income and retained earnings has not been delivered.

For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476 ;

- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .

All of the members have consented to the preparation of the abridged statement of income and retained earnings and the abridged statement of financial position for the year ending 31 December 2025 in accordance with Section 444(2A) of the Companies Act 2006.

Lynchwood Diagnostics Limited

Abridged Statement of Financial Position (continued)

31 December 2025

These abridged financial statements were approved by the board of directors and authorised for issue on 7 May 2026 , and are signed on behalf of the board by:

„„„„„„„„„„„„„

Mr P Bates Director

Company registration number: 07318073

Lynchwood Diagnostics Limited

Notes to the Abridged Financial Statements

Year Ended 31 December 2025

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 88 High Street, Ramsey, Huntingdon, Cambs, PE26 1BS.

2. Statement of compliance

These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

3.1 Basis of preparation

The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The abridged financial statements are prepared in sterling, which is the functional currency of the entity.

3.2 Revenue recognition

Turnover comprises the invoice value of goods and services supplied by the company during the year, net of Value Added Tax and trade discounts.

3.3 Foreign currencies

Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.

3.4 Tangible assets

Tangible fixed assets are stated at cost less depreciation.

3.5 Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Plant & machinery	-	25% reducing balance
Motor vehicle	-	25% reducing balance

3.6 Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

3.7 Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 3 (2024: 3 ).

5. Tangible assets

	£
Cost
At 1 January 2025 and 31 December 2025	7,433
	-------
Depreciation
At 1 January 2025	6,230
Charge for the year	301
	-------
At 31 December 2025	6,531
	-------
Carrying amount
At 31 December 2025	902
	-------
At 31 December 2024	1,203
	-------

6. Director's advances, credits and guarantees

During the year the director entered into the following advances and credits with the company:

	2025
	Balance brought forward	Amounts repaid	Balance outstanding
	£	£	£
Mr P Bates	( 684)	1,483	799
	----	-------	----

	2024
	Balance brought forward	Amounts repaid	Balance outstanding
	£	£	£
Mr P Bates	( 5,601)	4,917	( 684)
	-------	-------	----

The above loan is unsecured, interest free and repayable on demand.